Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial
- Federica Grosso
- , Nicola Steele
- , Silvia Novello
- , Anna K. Nowak
- , Sanjay Popat
- , Laurent Greillier
- , Thomas John
- , Natasha B. Leighl
- , Martin Reck
- , Paul Taylor
- , David Planchard
- , Jens Benn Sorensen
- , Mark A. Socinski
- , Ute von Wangenheim
- , Arsene Bienvenu Loembe
- , Jose Barrueco
- , Nassim Morsli
- , Giorgio Scagliotti
Research output: Contribution to journal › Article › peer-review
128
Link opens in a new tab
Citations
(Scopus)